Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy. Wu H, Ma W, Jiang C, Li N, et al. Ann Surg Oncol 2023;30:8572-8587.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu H, Ma W, Jiang C, Li N, et al. Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy. Ann Surg Oncol 2023;30:8572-8587.
PMID: 37667098